Sulwhasoo Launches New Brightening Serum ‘Lumiwise Brightening Ampoule Serum’
TORONTO, CANADA, March 4, 2026 /EINPresswire.com/ -- Global luxury skincare brand Sulwhasoo launches its new brightening line ‘Lumiwise’, debuting in Canada with its signature ampoule serum, the Lumiwise Brightening Ampoule Serum.
Formulated with Sulwhasoo’s proprietary GINSENG ECTOIN™ and the clinically recognized brightening ingredient NIACINAMIDE, the ampoule serum provides a dual-defence brightening solution that helps address early signs of melanin imbalance caused by internal aging and external stressors. By targeting aging-induced melanin overproduction, the formula works to reveal clearer, more luminous-looking skin.
Clinical testing has shown to reduce dark spot count by 36.6% in 4 weeks* with the combined effect of GINSENG ECTOIN™ (Sulwhasoo’s Korean Ginseng polysaccharides and Ectoin exclusive brightening complex) and NIACINAMIDE. Proven performance across multiple skin tones, with results showing:
100%** improvement in overall skin tone brightness
96%** improvement in the appearance of external dark spots
100%** improvement in the appearance of pigmentation
Sulwhasoo LUMIWISE BRIGHTENING AMPOULE SERUM features a Silk Cashmere Formula that melts gently into the skin, delivering hydration with an ultra-soft, glowy finish.
The Sulwhasoo Lumiwise line is available in Canada:
Lumiwise Brightening Ampoule Serum | 30mL, $176
Lumiwise Brightening Essence Water | 150mL, $122
Lumiwise Discoloration Corrector | 30mL, $176
Shop at Holt Renfrew, Amazon and Aritaum.
About Sulwhasoo
Sulwhasoo is a global luxury skincare brand under Amorepacific, rooted in decades of Korean Ginseng research and holistic skin science. Combining traditional Korean herbal ingredients with advanced skincare technology, Sulwhasoo develops high-performance formulations designed to support skin balance, clarity, and long-term skin vitality. In Canada, Sulwhasoo is available at select retail partners, including Sephora, Holt Renfrew, Aritaum and Amazon.
Disclaimers
*Instrumental result, 31 women, after 4 weeks of use.
**Percentage of subjects showing improvement from the instrumental measurement result, twice daily use for 8 weeks. Test Period: Oct 28-Dec 31, 2024, Subjects: Age 34-55, 31 women
For more media information, please contact mandy@caneast.ca
DOWNLOAD HIGH RES IMAGES HERE
Formulated with Sulwhasoo’s proprietary GINSENG ECTOIN™ and the clinically recognized brightening ingredient NIACINAMIDE, the ampoule serum provides a dual-defence brightening solution that helps address early signs of melanin imbalance caused by internal aging and external stressors. By targeting aging-induced melanin overproduction, the formula works to reveal clearer, more luminous-looking skin.
Clinical testing has shown to reduce dark spot count by 36.6% in 4 weeks* with the combined effect of GINSENG ECTOIN™ (Sulwhasoo’s Korean Ginseng polysaccharides and Ectoin exclusive brightening complex) and NIACINAMIDE. Proven performance across multiple skin tones, with results showing:
100%** improvement in overall skin tone brightness
96%** improvement in the appearance of external dark spots
100%** improvement in the appearance of pigmentation
Sulwhasoo LUMIWISE BRIGHTENING AMPOULE SERUM features a Silk Cashmere Formula that melts gently into the skin, delivering hydration with an ultra-soft, glowy finish.
The Sulwhasoo Lumiwise line is available in Canada:
Lumiwise Brightening Ampoule Serum | 30mL, $176
Lumiwise Brightening Essence Water | 150mL, $122
Lumiwise Discoloration Corrector | 30mL, $176
Shop at Holt Renfrew, Amazon and Aritaum.
About Sulwhasoo
Sulwhasoo is a global luxury skincare brand under Amorepacific, rooted in decades of Korean Ginseng research and holistic skin science. Combining traditional Korean herbal ingredients with advanced skincare technology, Sulwhasoo develops high-performance formulations designed to support skin balance, clarity, and long-term skin vitality. In Canada, Sulwhasoo is available at select retail partners, including Sephora, Holt Renfrew, Aritaum and Amazon.
Disclaimers
*Instrumental result, 31 women, after 4 weeks of use.
**Percentage of subjects showing improvement from the instrumental measurement result, twice daily use for 8 weeks. Test Period: Oct 28-Dec 31, 2024, Subjects: Age 34-55, 31 women
For more media information, please contact mandy@caneast.ca
DOWNLOAD HIGH RES IMAGES HERE
Mandy Siu
CANEAST
mandy@caneast.ca
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


